Hippocampal remodelling after MDMA neurotoxicity: A single case study

References

• Affolter F. Perceptual processes as prerequisites for complex human behaviour. Int Rehabil Med 1981; 3: 3–10
   PubMedGoogle Scholar
• Budisavljevic MN, Stewart L, Sahn SA, Ploth DW. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine (‘Ecstasy’) abuse. Am J Med Sci 2003; 326: 89–93
   PubMed Web of Science ®Google Scholar
• Eichenbaum H, Otto T, Cohen NJ. The hippocampus – what does it do?. Behav Neural Biol 1992; 57: 2–36
   PubMedGoogle Scholar
• Daniels-Zide, E, Ben-Yishay, Y. 2000. Holistic day program. In. Chirstensen and Uzzel. International handbook of neuropsychological rehabilitation. Dordrecht/Boston: Kluwer Academic/Plenum Publishers.
   Google Scholar
• Duffau H. Brain plasticity: from pathophysiological mechanisms to therapeutic applications. J Clin Neurosci 2006; 13: 885–897
   PubMed Web of Science ®Google Scholar
• Fallon JK, Shah D, Kicman AT, et al. Action of MDMA (ecstasy) and its metabolites on arginine vasopressin release. Ann NY Acad Sci 2002; 965: 399–409
   PubMed Web of Science ®Google Scholar
• Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult neurogenesis in the hippocampal formation. Nat Neurosci 1999; 2: 260–265
   PubMed Web of Science ®Google Scholar
• Gouzoulis-Mayfrank E, Timm B, Rezk M, Hensen G, Daumann J. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 819–827
   PubMedGoogle Scholar
• Guo Q, Fu W, Sopher BL, et al. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 1999; 5: 101–107
   PubMed Web of Science ®Google Scholar
• Jacobsen LK, Mencl WE, Pugh KR, Skudlarski P, Krystal JH. Preliminary evidence of hippocampal dysfunction in adolescent MDMA (‘ecstasy’) users: possible relationship to neurotoxic effects. Psychopharmachology (Berlin) 2004; 173: 383–390
   PubMedGoogle Scholar
• Lupi A, Bertagnoni G, Salgarello M, Orsolon P, Malfatti V, Zanco P. Cerebellar vermis relative hypermetabolism: an almost constant PET finding in injured brain. Clin Nucl Med 2007; 32: 445–451
   PubMedGoogle Scholar
• Marchesi C, Tonna M, Maggini C. Obsessive-compulsive disorder followed by psychotic episode in long-term ecstasy misuse. World J Biol Psychiatry 2007; 10: 1–4
   Google Scholar
• McEwen BS. Effects of Adverse Experiences for Brain Structure and Function. Biol Psychiatry 2000; 48: 721–731
   PubMed Web of Science ®Google Scholar
• McEwen BS, Magarinos AM. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharm 2001; 16: 7–19
   PubMed Web of Science ®Google Scholar
• Pantel J, O'Leary DS, Cretsinger K, et al. A new method for the in vivo volumetric measurement of the human-hippocampus with high neuroanatomical accuracy. Hippocampus 2000; 10: 752–758
   PubMed Web of Science ®Google Scholar
• Peng W, Simantov R. Altered gene expression in frontal cortex and midbrain of 3,4-methylenedioxymethamphetamine (MDMA) treated mice: differential regulation of GABA transporter subtypes. J Neurosci Res 2003; 72: 250–258
   PubMedGoogle Scholar
• Perini, G, Nifosì, F, Toffanin, T, Gatto, C, Ghelli, G, Amistà, P. 2004. Recurrent major depression and nuclear magnetic resonance: a volumetric study. In: Proceedings of the 7th Congress of European Society for Clinical Neuropharmacology. J Neural Transm. 111(5): I-XLVII abstract.
   Google Scholar
• Pruessner JC, Li LM, Serles W, et al. Volumetry of hippocampus and amygdala with high-resolution mri and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 2000; 10: 433–442
   PubMed Web of Science ®Google Scholar
• Quinton MS, Yamamoto BK. Causes and consequences of methamphetamine and MDMA toxicity. AAPS J 2006; 8: 337–347
   PubMed Web of Science ®Google Scholar
• Ricaurte GA, Yuan J, McCann UD. 3,4-methylenedioxymethamphetamine (Ecstasy)-induced serotonin neurotoxicity: studies in animals. Neuropsychobiology 2000; 42: 5–10
   PubMed Web of Science ®Google Scholar
• Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R. MDMA (‘ecstasy’) consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 1998; 52: 85–90
   PubMed Web of Science ®Google Scholar
• Sheline YI, Gado MH, Kraemer HC. Untreated depression and hippocampal volume loss. Am J Psychiatry 2003; 160: 1516–1518
   PubMed Web of Science ®Google Scholar
• Voss HU, Uluc AM, Dyke JP, et al. Possible axonal regrowth in late recovery from the minimally conscious state. J Clin Invest 2006; 116: 2005–2011
   PubMed Web of Science ®Google Scholar
• Warner-Schmidt JL, Duman RS. Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 2006; 16: 239–249
   PubMed Web of Science ®Google Scholar
• Yucel M, Lubman DI. Neurocognitive and Neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev 2007; 26: 33–39
   PubMed Web of Science ®Google Scholar